Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
NCT ID: NCT06394986
Last Updated: 2024-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2018-06-18
2019-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Access Creation for Hemodialysis: Association With Structural Changes of the Heart
NCT00368147
Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula
NCT06199609
Hemodialysis in the Elderly (70yrs & Older)
NCT03065972
Tunneled Dialysis Catheters Versus Non-tunneled Dialysis Catheters as First-line for Renal Replacement Therapy in the ICU
NCT03496935
Ventriculo-Arterial Coupling and Intra-Dialytic Changes in Hemodialysis Patients: Prognostic Insights
NCT06622928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Hemodialysis session
Change of arteriovenous fistula volume blood flow / cardiac output ratio in patients with chronic heart failure (NYHA I-II classes) and with preserved ejection fraction as a result of a hemodialysis session will be explored.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemodialysis session
Change of arteriovenous fistula volume blood flow / cardiac output ratio in patients with chronic heart failure (NYHA I-II classes) and with preserved ejection fraction as a result of a hemodialysis session will be explored.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years
* maintenance ("chronic") hemodialysis,
* native arteriovenous fistula,
* arteriovenous fistula volume blood flow ≥1 l/min,
* arteriovenous fistula volume blood flow / cardiac output ratio \< 0.3,
* interdialysis weight gain \<5% of "dry" body weight,
* sufficient hemodialysis dose (eKt/V \> 1.2),
* chronic heart failure (NYHA I-II classes only),
* preserved left ventricular ejection fraction (≥50%),
* absence of arrhythmias (except first-degree atrioventricular block block),
* absence of heart valve disease (except mitral regurgitation grade I-II),
* absence of intradialysis hypo/hypertension
* "long" interdialysis interval (3 days).
Exclusion Criteria
* arrhythmias (except first-degree atrioventricular block) after hemodialysis.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moscow Regional Research and Clinical Institute (MONIKI)
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexey Zulkarnaev
Leading Researcher in Surgical Department of Kidney Transplantation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexey B Zulkarnaev, MD, Prof.
Role: PRINCIPAL_INVESTIGATOR
Moscow Regional Research and Clinical Institute (MONIKI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Moscow Regional Research and Clinical Institute (MONIKI)
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABZ_310518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.